Summary: Dr. Richard Miller of Psychepedia interviews MAPS Founder Rick Doblin, Ph.D., about MAPS’ work to develop psychedelics and marijuana into FDA-approved prescription treatments for serious mental health conditions. Doblin speaks about the history of psychedelic science, details the results from published research into MDMA-assisted psychotherapy for PTSD, and highlights the significance of MAPS’ upcoming 30th anniversary.
Originally appearing here.
Host Dr. Richard Louis Miller interviews Dr. Rick Doblin, Historic Founder, and Executive Director, of MAPS: The Multidisciplinary Association for Psychedelic Studies, now celebrating its 25th year as the world ‘s foremost pharmaceutical organization specializing in psychedelic medicine research.